An observational study in Hip Arthropathy and Orthopedic Disorder, sponsored by Limacorporate S.p.a. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-19.
Sponsored by Limacorporate S.p.a · Observational
This is a post-market, monocentric Retrospective and prospective, observational, open-label and baseline clinical study in order to evaluate the performance and safety of Revision LR femoral stem
657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.
This study's enrollment of 64 is below the median of 126 across 201 observational studies indexed under Musculoskeletal Diseases.
Browse Musculoskeletal Diseases studies →Limacorporate S.p.a is the lead sponsor of 31 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who underwent a hip arthroplasty with Revision LR stem at Spedali Civili (Brescia) from 1st January 2012 will be screened for the retrospective part of the study. Patients who require a hip arthroplasty with a large femur resection will be screened for the prospective part of the study.
Exclusion Criteria:
Revision LR is a modular femoral stem used for hip replacement
Revision rate of the femoral component
Revision rate of the femoral component for aseptic loosening, not resultant from a tumor recurrence.
Time frame: from baseline to FU 10 Years
Implant stability
Implant stability via radiographic assessment of the X-rays at followup, using immediate postoperative X-rays as baseline;
Time frame: from baseline to FU 10 Years
Functionality evaluation
Functionality of the patients measured via Harris Hip Score up to last available FU
Time frame: from baseline to FU 10 Years
Incidence of device-related adverse events or serious adverse events.
Incidence of device-related adverse events or serious adverse events
Time frame: from baseline to FU 10 Years
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Limacorporate S.p.a